20/20 Biolabs, Inc. Common Stock (AIDX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

20/20 Biolabs, Inc. Common Stock (AIDX) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $4.9M, listed on NASDAQ, employing roughly 13 people, carrying a beta of -0.42 to the broader market. 20/20 GeneSystems, Inc. Led by Jonathan Cohen, public since 2023-06-15.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for AIDX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →